KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xylem (XYL) Other Operating Expenses (2017 - 2025)

Xylem has reported Other Operating Expenses over the past 10 years, most recently at $16.0 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $16.0 million for Q4 2025, up 140.0% from a year ago — trailing twelve months through Dec 2025 was -$31.0 million (up 32.61% YoY), and the annual figure for FY2025 was -$31.0 million, up 32.61%.
  • Other Operating Expenses for Q4 2025 was $16.0 million at Xylem, up from -$37.0 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for XYL hit a ceiling of $16.0 million in Q4 2025 and a floor of -$40.0 million in Q4 2024.
  • Median Other Operating Expenses over the past 5 years was -$1.5 million (2023), compared with a mean of -$7.5 million.
  • Biggest five-year swings in Other Operating Expenses: crashed 3900.0% in 2024 and later soared 140.0% in 2025.
  • Xylem's Other Operating Expenses stood at $2.0 million in 2021, then crashed by 50.0% to $1.0 million in 2022, then tumbled by 200.0% to -$1.0 million in 2023, then crashed by 3900.0% to -$40.0 million in 2024, then soared by 140.0% to $16.0 million in 2025.
  • The last three reported values for Other Operating Expenses were $16.0 million (Q4 2025), -$37.0 million (Q3 2025), and -$10.0 million (Q1 2025) per Business Quant data.